Relapse-free survival and pd-l1 expression in first high-and low-grade relapsed luminal, basal and double-negative p53-mutant non-muscular invasive bladder cancer depending on previous chemo-and immunotherapy
Blinova E.,
Enikeev D.,
Roshchin D.,
Samyshina E.,
Deryabina O.,
Tertychnyy A.,
Blinov D.,
Kogan E.,
Dudina M.,
Barakat H.,
Merinov D.,
Kachmazov A.,
Serebrianyi S.,
Potoldykova N.,
Perepechin D.
Связанные документы (рекомендация CORE)